Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases
about
Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: Analysis of 89 cases.
P2860
Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@ast
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@en
type
label
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@ast
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@en
prefLabel
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@ast
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@en
P2093
P2860
P356
P1476
Immunochemotherapy for primary ...... ospective analysis of 18 cases
@en
P2093
Xiao-Yan Li
Xue-Fei Sun
Xue-Yan Bai
Ya-Ming Wang
Yuan-Bo Liu
Yue-Dan Chen
P2860
P304
P356
10.3892/MCO.2015.566
P50
P577
2015-05-12T00:00:00Z